Unknown

Dataset Information

0

Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial.


ABSTRACT: Low serum albumin is common and associated with protein-energy wasting, inflammation, and poor outcomes in maintenance hemodialysis (MHD) patients. We hypothesized that in-center (in dialysis clinic) provision of high-protein oral nutrition supplements (ONS) tailored for MHD patients combined with anti-oxidants and anti-inflammatory ingredients with or without an anti-inflammatory appetite stimulator (pentoxifylline, PTX) is well tolerated and can improve serum albumin concentration.Between January 2008 and June 2010, 84 adult hypoalbuminemic (albumin <4.0 g/dL) MHD outpatients were double-blindly randomized to receive 16 weeks of interventions including ONS, PTX, ONS with PTX, or placebos. Nutritional and inflammatory markers were compared between the four groups.Out of 84 subjects (mean ± SD; age, 59?±?12 years; vintage, 34?±?34 months), 32 % were Blacks, 54 % females, and 68 % diabetics. ONS, PTX, ONS plus PTX, and placebo were associated with an average change in serum albumin of +0.21 (P?=?0.004), +0.14 (P?=?0.008), +0.18 (P?=?0.001), and +0.03 g/dL (P?=?0.59), respectively. No related serious adverse events were observed. In a predetermined intention-to-treat regression analysis modeling post-trial serum albumin as a function of pre-trial albumin and the three different interventions (ref = placebo), only ONS without PTX was associated with a significant albumin rise (+0.17?±?0.07 g/dL, P?=?0.018).In this pilot-feasibility, 2?×?2 factorial, placebo-controlled trial, daily intake of a CKD-specific high-protein ONS with anti-inflammatory and anti-oxidative ingredients for up to 16 weeks was well tolerated and associated with slight but significant increase in serum albumin levels. Larger long-term controlled trials to examine hard outcomes are indicated.

SUBMITTER: Rattanasompattikul M 

PROVIDER: S-EPMC3830006 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial.

Rattanasompattikul Manoch M   Molnar Miklos Z MZ   Lee Martin L ML   Dukkipati Ramanath R   Bross Rachelle R   Jing Jennie J   Kim Youngmee Y   Voss Anne C AC   Benner Debbie D   Feroze Usama U   Macdougall Iain C IC   Tayek John A JA   Norris Keith C KC   Kopple Joel D JD   Unruh Mark M   Kovesdy Csaba P CP   Kalantar-Zadeh Kamyar K  

Journal of cachexia, sarcopenia and muscle 20130920 4


<h4>Background</h4>Low serum albumin is common and associated with protein-energy wasting, inflammation, and poor outcomes in maintenance hemodialysis (MHD) patients. We hypothesized that in-center (in dialysis clinic) provision of high-protein oral nutrition supplements (ONS) tailored for MHD patients combined with anti-oxidants and anti-inflammatory ingredients with or without an anti-inflammatory appetite stimulator (pentoxifylline, PTX) is well tolerated and can improve serum albumin concent  ...[more]

Similar Datasets

| S-EPMC5549289 | biostudies-other
| S-EPMC3051071 | biostudies-literature
| S-EPMC7230691 | biostudies-literature
| S-EPMC6484692 | biostudies-literature
| S-EPMC5038350 | biostudies-literature
| S-EPMC8159563 | biostudies-literature
| S-EPMC7241803 | biostudies-literature
| S-EPMC5392145 | biostudies-literature
| S-EPMC10256404 | biostudies-literature
| S-EPMC4484515 | biostudies-literature